Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 44
16
Diseases
219
Unique genes
0.113
Avg. similarity score
Osteochondrodysplasias
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Osteochondrodysplasias
Spondyloepimetaphyseal dysplasia
Spondyloepiphyseal dysplasia
Congenital cartilage disorder
Connective tissue disease
Carpal tunnel syndrome
B3GALT6-congenital disorder of glycosylation
Mixed connective tissue disease
Cerebrocostomandibular syndrome
Copper metabolism disorder
Hoxha-aliu syndrome
Rhizomelic dysplasia, ain-naz type
schneckenbecken dysplasia
spondyloepimetaphyseal dysplasia with joint laxity, type 3
spondyloepimetaphyseal dysplasia, genevieve type
spondyloepiphyseal dysplasia, kondo-fu type
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Osteochondrodysplasias | 5 | 5 | 33 |
| Spondyloepimetaphyseal dysplasia | 5 | 5 | 25 |
| Spondyloepiphyseal dysplasia | 5 | 5 | 18 |
| Congenital cartilage disorder | 4 | 4 | 30 |
| Connective tissue disease | 4 | 4 | 117 |
| Carpal tunnel syndrome | 3 | 3 | 63 |
| B3GALT6-congenital disorder of glycosylation | 2 | 2 | 1 |
| Mixed connective tissue disease | 2 | 2 | 24 |
| Cerebrocostomandibular syndrome | 1 | 1 | 1 |
| Copper metabolism disorder | 1 | 1 | 1 |
| Hoxha-aliu syndrome | 1 | 1 | 1 |
| Rhizomelic dysplasia, ain-naz type | 1 | 1 | 1 |
| schneckenbecken dysplasia | 1 | 1 | 1 |
| spondyloepimetaphyseal dysplasia with joint laxity, type 3 | 1 | 1 | 1 |
| spondyloepimetaphyseal dysplasia, genevieve type | 1 | 1 | 1 |
| spondyloepiphyseal dysplasia, kondo-fu type | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| COL2A1 | 5 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias, Spondyloepimetaphyseal dysplasia and 1 more |
| TRPV4 | 5 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias, Spondyloepimetaphyseal dysplasia and 1 more |
| COL11A1 | 4 / 16 | Carpal tunnel syndrome, Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| COL11A2 | 4 / 16 | Carpal tunnel syndrome, Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| COMP | 4 / 16 | Carpal tunnel syndrome, Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| HSPG2 | 4 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias, Spondyloepiphyseal dysplasia |
| MATN3 | 4 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias, Spondyloepimetaphyseal dysplasia |
| ADAMTSL2 | 3 / 16 | Carpal tunnel syndrome, Congenital cartilage disorder, Osteochondrodysplasias |
| B3GALT6 | 3 / 16 | B3GALT6-congenital disorder of glycosylation, Spondyloepimetaphyseal dysplasia, Spondyloepiphyseal dysplasia |
| CHST3 | 3 / 16 | Congenital cartilage disorder, Osteochondrodysplasias, Spondyloepiphyseal dysplasia |
| COL10A1 | 3 / 16 | Carpal tunnel syndrome, Congenital cartilage disorder, Osteochondrodysplasias |
| COL9A1 | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| COL9A2 | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| COL9A3 | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| DYM | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| FLNA | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| FLNB | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| GLB1 | 3 / 16 | Congenital cartilage disorder, Osteochondrodysplasias, Spondyloepiphyseal dysplasia |
| LIFR | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| PTH1R | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| SLC26A2 | 3 / 16 | Congenital cartilage disorder, Connective tissue disease, Osteochondrodysplasias |
| TRAPPC2 | 3 / 16 | Connective tissue disease, Osteochondrodysplasias, Spondyloepiphyseal dysplasia |
| ACAN | 2 / 16 | Spondyloepimetaphyseal dysplasia, Spondyloepiphyseal dysplasia |
| BASP1 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| BCL2 | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| BMPR1B | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| CCS | 2 / 16 | Carpal tunnel syndrome, Copper metabolism disorder |
| CDH4 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| CDYL | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| DDR2 | 2 / 16 | Connective tissue disease, Spondyloepimetaphyseal dysplasia |
| DLL3 | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| EFEMP1 | 2 / 16 | Carpal tunnel syndrome, Connective tissue disease |
| ERI1 | 2 / 16 | Hoxha-aliu syndrome, Spondyloepimetaphyseal dysplasia |
| EXOC6B | 2 / 16 | Spondyloepimetaphyseal dysplasia, spondyloepimetaphyseal dysplasia with joint laxity, type 3 |
| FBN1 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| FBN2 | 2 / 16 | Carpal tunnel syndrome, Connective tissue disease |
| FLT1 | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| GNPNAT1 | 2 / 16 | Osteochondrodysplasias, Rhizomelic dysplasia, ain-naz type |
| HDAC4 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| HHEX | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| HOXA11 | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| KCNMB2 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| KDR | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| LPAR3 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| LRP11 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| MBTPS1 | 2 / 16 | Spondyloepiphyseal dysplasia, spondyloepiphyseal dysplasia, kondo-fu type |
| MYRIP | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| NANS | 2 / 16 | Spondyloepimetaphyseal dysplasia, spondyloepimetaphyseal dysplasia, genevieve type |
| OFD1 | 2 / 16 | Connective tissue disease, Spondyloepiphyseal dysplasia |
| PBLD | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| PCLO | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| PFKP | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| PTGIS | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| PTPRN2 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| RPL13 | 2 / 16 | Spondyloepimetaphyseal dysplasia, Spondyloepiphyseal dysplasia |
| SLC35D1 | 2 / 16 | Connective tissue disease, schneckenbecken dysplasia |
| SLC39A13 | 2 / 16 | Connective tissue disease, Spondyloepimetaphyseal dysplasia |
| SLC4A10 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| SNRPB | 2 / 16 | Cerebrocostomandibular syndrome, Mixed connective tissue disease |
| SNRPC | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| SOST | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| SOX14 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| SPOP | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| SSX2IP | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| TGFB1 | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| TRIM55 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| TRPS1 | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
| UIMC1 | 2 / 16 | Connective tissue disease, Mixed connective tissue disease |
| VEGFA | 2 / 16 | Congenital cartilage disorder, Osteochondrodysplasias |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ECM proteoglycans | Reactome | 16 / 51 | 17.2× | 3.52e-16 | 1.47e-13 ✓ sig. |
| Non-integrin membrane-ECM interactions | Reactome | 12 / 24 | 27.4× | 2.23e-15 | 8.05e-13 ✓ sig. |
| Assembly of collagen fibrils and other multimeric structures | Reactome | 13 / 51 | 14.0× | 4.46e-12 | 8.54e-10 ✓ sig. |
| Collagen biosynthesis and modifying enzymes | Reactome | 14 / 67 | 11.5× | 1.24e-11 | 2.17e-9 ✓ sig. |
| Collagen chain trimerization | Reactome | 12 / 44 | 15.0× | 1.26e-11 | 2.20e-9 ✓ sig. |
| Integrin cell surface interactions | Reactome | 14 / 81 | 9.5× | 1.84e-10 | 2.50e-8 ✓ sig. |
| Cytoskeleton in muscle cells | KEGG | 22 / 232 | 5.2× | 2.32e-10 | 3.07e-8 ✓ sig. |
| Collagen degradation | Reactome | 10 / 52 | 10.5× | 2.68e-8 | 2.09e-6 ✓ sig. |
| MET activates PTK2 signaling | Reactome | 8 / 30 | 14.6× | 4.46e-8 | 3.22e-6 ✓ sig. |
| NCAM1 interactions | Reactome | 7 / 21 | 18.3× | 5.70e-8 | 4.01e-6 ✓ sig. |
| Signaling by PDGF | Reactome | 8 / 33 | 13.3× | 1.01e-7 | 6.58e-6 ✓ sig. |
| Extracellular matrix organization | Reactome | 6 / 15 | 21.9× | 1.50e-7 | 9.29e-6 ✓ sig. |
| Focal adhesion | KEGG | 17 / 203 | 4.6× | 1.75e-7 | 1.06e-5 ✓ sig. |
| Molecules associated with elastic fibres | Reactome | 8 / 38 | 11.5× | 3.29e-7 | 1.86e-5 ✓ sig. |
| Protein digestion and absorption | KEGG | 12 / 103 | 6.4× | 3.55e-7 | 1.99e-5 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| skeletal system development | GO:0001501 | 28 / 151 | 15.8× | 9.78e-26 | 3.32e-22 ✓ sig. |
| cartilage development | GO:0051216 | 16 / 89 | 15.3× | 6.05e-15 | 4.07e-12 ✓ sig. |
| collagen fibril organization | GO:0030199 | 14 / 65 | 18.4× | 2.19e-14 | 1.34e-11 ✓ sig. |
| ossification | GO:0001503 | 15 / 110 | 11.6× | 2.94e-12 | 1.22e-9 ✓ sig. |
| chondrocyte differentiation | GO:0002062 | 11 / 61 | 15.4× | 1.11e-10 | 3.17e-8 ✓ sig. |
| endochondral ossification | GO:0001958 | 8 / 31 | 22.0× | 1.96e-9 | 4.06e-7 ✓ sig. |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 10 / 67 | 12.7× | 5.51e-9 | 1.02e-6 ✓ sig. |
| bone mineralization | GO:0030282 | 9 / 56 | 13.7× | 1.66e-8 | 2.66e-6 ✓ sig. |
| bone development | GO:0060348 | 10 / 76 | 11.2× | 1.93e-8 | 3.03e-6 ✓ sig. |
| negative regulation of ossification | GO:0030279 | 7 / 27 | 22.1× | 2.01e-8 | 3.13e-6 ✓ sig. |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 5 / 9 | 47.4× | 2.56e-8 | 3.85e-6 ✓ sig. |
| growth plate cartilage development | GO:0003417 | 5 / 11 | 38.8× | 9.21e-8 | 1.12e-5 ✓ sig. |
| cartilage condensation | GO:0001502 | 6 / 21 | 24.4× | 1.13e-7 | 1.34e-5 ✓ sig. |
| chondrocyte development | GO:0002063 | 6 / 21 | 24.4× | 1.13e-7 | 1.34e-5 ✓ sig. |
| intraciliary retrograde transport | GO:0035721 | 5 / 14 | 30.5× | 3.88e-7 | 3.78e-5 ✓ sig. |